Cargando…

Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome

The goal of this study was to assess the clinical performance of an investigational in vitro fecal calprotectin immunoassay for differentiating inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS). BACKGROUND: Fecal calprotectin is a stool biomarker that can assist in the detection o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, James P., Zierold, Claudia, Rode, Ashli M., Blocki, Frank A., Vaughn, Byron P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	ALIMENTARY TRACT: Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960147/ https://www.ncbi.nlm.nih.gov/pubmed/32324678 http://dx.doi.org/10.1097/MCG.0000000000001359

Ejemplares similares

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
por: Maconi, Giovanni, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group
por: Arrigo, Serena, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation
por: Tanaka, Yukari, et al.
Publicado: (2022)

Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease
por: Suskind, David L., et al.
Publicado: (2018)

IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease
por: Tremelling, Mark, et al.
Publicado: (2007)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia
por: Katsumata, Ryo, et al.
Publicado: (2023)

Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI
por: Zhang, Yanli, et al.
Publicado: (2023)

Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey
por: Baars, J. E., et al.
Publicado: (2012)

Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
por: Ishige, Takashi, et al.
Publicado: (2023)

Current Practice and Perception of Screening for Medication Adherence in Inflammatory Bowel Disease
por: Trindade, Arvind J., et al.
Publicado: (2011)

Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome
por: Kawamura, Yurika, et al.
Publicado: (2019)

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease()()
por: Jabri*, ‡, §, Bana, et al.
Publicado: (2000)

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases
por: Zhang, Hu, et al.
Publicado: (2020)

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine
por: Siniscalchi, Monica, et al.
Publicado: (2020)

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey
por: Marasco, Giovanni, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
por: Elli, Luca, et al.
Publicado: (2022)

Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
por: Schreiber, Stefan, et al.
Publicado: (2018)

Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey
por: Ueno, Fumiaki, et al.
Publicado: (2016)

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)
por: Nakase, Hiroshi, et al.
Publicado: (2022)

Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
por: Nakase, Hiroshi, et al.
Publicado: (2023)

A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan
por: Ando, Katsuyoshi, et al.
Publicado: (2021)

Effect of Chicory-derived Inulin on Abdominal Sensations and Bowel Motor Function
por: Azpiroz, Fernando, et al.
Publicado: (2017)

Implementation of a Defecation Posture Modification Device: Impact on Bowel Movement Patterns in Healthy Subjects
por: Modi, Rohan M., et al.
Publicado: (2019)

Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)
por: van der Sloot, Kimberley Wilhelmina Johanna, et al.
Publicado: (2018)

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study
por: Shinzaki, Shinichiro, et al.
Publicado: (2021)

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients
por: Jordi, Sebastian Bruno Ulrich, et al.
Publicado: (2022)

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
por: Kakuta, Yoichi, et al.
Publicado: (2018)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Patients with dyspepsia have impaired mucosal integrity both in the duodenum and jejunum: in vivo assessment of small bowel mucosal integrity using baseline impedance
por: Nakagawa, Kenichiro, et al.
Publicado: (2019)

The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study
por: Taylor, Douglas C.A., et al.
Publicado: (2019)

The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease
por: Osredkar, Joško, et al.
Publicado: (2021)

Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection
por: Hasnain, Sumaira Z., et al.
Publicado: (2010)

Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
por: Camargo, Simone M.R., et al.
Publicado: (2009)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9m01mpdi7amaveg8v9nnkkb9l2